Try our Advanced Search for more refined results
Competition
Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.
Sign up for a 7-day FREE trial today!
Latest News in Competition
-
February 21, 2025
FTC's Holyoak Has Her Eyes On DeepSeek
Federal Trade Commission member Melissa Holyoak suggested Friday that DeepSeek, the Chinese artificial intelligence startup whose rise has roiled AI markets, could have competed unfairly if it really trained its model using ChatGPT in violation of OpenAI's policies, as has been suggested.
-
February 21, 2025
Apple Can Claw Back Mistakenly Produced Docs In Epic Fight
A California federal magistrate judge said Friday that Apple can claw back two documents the tech giant said it accidentally produced during discovery for an antitrust suit brought by Epic Games, rejecting the game developer's assertion that Apple's bid was "opportunistic."
-
February 21, 2025
Drugmakers Slam 'Untimely' Claims In Employers' Antitrust Suit
Pharmaceutical companies targeted by sweeping antitrust lawsuits from major employers, including Target, Lowe's and American Airlines, have asked a Pennsylvania federal judge to trim conspiracy claims from a lawsuit accusing them of orchestrating illegal agreements for price-fixing and customer allocation, arguing the allegation was unsupported and untimely.
-
February 21, 2025
MSN Calls Novartis' Entresto Delisting Protest 'Disingenuous'
Novartis' claim that there's no rush to decide whether a patent covering its blockbuster cardiovascular drug Entresto should be removed from a key drug database is "disingenuous and a complete about-face," MSN Pharmaceuticals has told a Delaware federal judge.
-
February 21, 2025
Eli Lilly Has Exclusivity Over Weight Loss Drug, FDA Says
The U.S. Food and Drug Administration asked a Texas federal court to reject a request for an injunction that would allow compounding pharmacies to produce a lucrative weight loss drug, saying Thursday the agency based its decision on sound facts and it was within its authority.
Areas of Coverage
- AGENCIES
- U.S. Department of Justice, Antitrust Division
- Federal Trade Commission, Bureau of Competition
- European Commission, Competition Directorate
- UK Competition and Markets Authority
- Germany’s Federal Cartel Office
- China’s Ministry Of Commerce
- Japan Fair Trade Commission
- Korea Fair Trade Commission
- Canada’s Competition Bureau
- Brazil’s Council for Economic Defense
- POLICY & REGULATION
- Clayton Act
- Federal Trade Commission Act
- Foreign Corrupt Practices Act
- Racketeer Influenced and Corrupt Organizations Act
- Robinson-Patman Act
- Sherman Act
- International antitrust legislation and regulation
- ENFORCEMENT
- Criminal charges over antitrust issues
- Global cartel investigations and actions
- Merger reviews and second requests
- Merger challenges and divestiture orders
- Anti-monopoly actions
- Pharmaceutical pay-for-delay challenges
- Bid-rigging probes
- Kickback, bribery, and corruption cases
- Challenges to state aid and other subsidies
- LITIGATION
- Antitrust class actions
- Price-fixing cases
- Illegal monopoly suits
- PROFILES
- Personnel moves
- Profiles of competition practices
Readership
- Antitrust and competition lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals